INADEQUACY OF CHLORPROGUANIL 20 mg PER WEEK AS CHEMOPROPHYLAXIS FOR FALCIPARUM MALARIA IN KENYA

The Lancet

Volumn 329, Issue 8525, 1987, Pages 125-128

  Watkins, W M ^a,b,c,d   Oloo, A J ^a,b,c,d   Gilles, H M ^a,b,c,d   Brandling Bennett, A D ^a,b,c,d   Howells, R E ^a,b,c,d   Koech, D K ^a,b,c,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORCYCLOGUANIL; CHLOROQUINE; CHLORPROGUANIL; PYRIMETHAMINE; SULFADOXINE;

CHEMOPROPHYLAXIS; DOSE RESPONSE; DRUG DOSE; DRUG EFFICACY; DRUG RESISTANCE; DRUG RESPONSE; DRUG THERAPY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRESCHOOL CHILD; PREVENTION; PRIORITY JOURNAL; SCHOOL CHILD; THERAPY;

ADOLESCENT; CHILD; CHLOROGUANIDE; CLINICAL TRIALS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KENYA; MALARIA; MALE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RANDOM ALLOCATION; SULFADOXINE;

EID: 0023145051     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)91966-0     Document Type: Article

References (21)

1. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya
2. Mass treatment with pyrimethamine A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni Kenya September 1952-September 1953
3. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors
4. Chemoprophylaxis of malaria in non-immune residents in Dar es Salaam, Tanzania
5. Leads from the MMWR. Revised recommendations for preventing malaria in travellers to areas with chloroquine-resistant Plasmodium falciparum.
6. Clinical pharmacokinetics of antimalarial drugs
7. N-3:4-dichlorophenyl-N-isopropyldiguanide a derivative of proguanil highly active in avian malaria
8. Experiments with antimalarial drugs in man. III. Experiments with compound 5943
9. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya
10. Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on the Kenya coast
11. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya
12. Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerised curve fitting
13. Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique
14. Field tnals with chlorproguanil in the prophylaxis of malaria in Ghana
15. A companson of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug sensitive and resistant strains of Plasmodium yoelii
16. In vitro demonstration of pyrimethamine resistance of'wild' Plasmodium falciparum in the Gambia
17. Maternal and foetal malana and E-B virus antibodies following ante-natal chlorproguanil therapy
18. Amodiaquine induced agranulocytosis and liver damage